Teresa H.
- Country
- Poland
- Department
- N/A
Research Overview
- A 52-week, randomised, double blind, multicentre, 2-arm parallel group trial assessing the efficacy and safety of CHF6001 (total daily dose 3200 μg) Dry Powder Inhaler (DPI) add-on to maintenance medium or high dose inhaled corticosteroid in combination with long-acting ß2-agonists in subjects with uncontrolled asthma
- Efficacy and Safety Evaluation of Astegolimab in Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study
- A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Data & Insights
Has run more than one trial at 16 of 217 partner sites.
Specializations
Allergic Rhinitis and Rhinoconjunctivitis
Teresa Hofman is involved in clinical research on seasonal allergic rhinitis, perennial allergic rhinitis, and birch pollen-induced allergic rhinoconjunctivitis, with attention to symptom control and rescue medication use. Her work also includes house dust mite-driven allergic rhinoconjunctivitis and related upper-airway allergy conditions.
- Birch pollen allergy
- Perennial nasal allergy
- House dust mite-induced rhinoconjunctivitis
Her clinical focus in this area centers on allergen immunotherapy and biologic treatment strategies for persistent nasal and ocular allergic disease.
Asthma and Airway Obstruction
Her research landscape includes severe asthma, inadequately controlled asthma, and asthma associated with allergic disease, together with broader chronic obstructive pulmonary disease care. The trial portfolio reflects interest in improving lung function and reducing exacerbations in patients with difficult-to-control airway disease.
- Severe asthma
- Asthma exacerbations
- COPD
She is active in studies of inhaled and anti-inflammatory therapies aimed at respiratory symptom relief and long-term disease control.
Atopic Dermatitis
Teresa Hofman is also engaged in research on moderate-to-severe atopic dermatitis, with emphasis on sustained disease management and treatment tolerability in adolescents and adults. This area highlights her interest in chronic inflammatory skin disease requiring long-term therapeutic support.
- Moderate-to-severe eczema
- Long-term tolerability
- Inflammatory skin disease
Her involvement extends to biologic approaches for controlling persistent cutaneous inflammation and associated disease burden.
Chronic Urticaria
Her clinical trial activity includes chronic spontaneous urticaria and broader chronic urticaria, focusing on symptom reduction and treatment response in patients with inadequate control on standard therapy. This area reflects a therapeutic interest in recurrent wheals and itching driven by persistent immune-mediated disease.
- Chronic spontaneous urticaria
- Antihistamine-refractory disease
- Urticaria activity
She contributes to the evaluation of targeted biologic options for improving disease control in refractory urticaria.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.